Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Skin issues from testosterone therapy in transgender men can be managed with combined dermatology and endocrinology care.

Combining Ayurvedic therapies with minoxidil is more effective for hair growth in men than using minoxidil alone.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Hair loss in women can be treated with hormone therapy.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

PCPA induces hypersexual behavior in male rats regardless of age or castration status.

Microneedling can effectively promote new hair growth in men with hair loss who didn't improve with traditional treatments.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Combining growth factors with minoxidil improves hair growth more than minoxidil alone.

New therapy helps treat hair loss.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Combining laser light therapy and growth factor treatment improves hair growth in people with hair loss.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Antiandrogen treatment can reduce sexual enjoyment in women with excess male hormones, especially those in stable relationships.

Platelet-rich plasma therapy improves hair growth and health in androgenetic alopecia better than some FDA-approved treatments.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

The combination of topical minoxidil and oral finasteride improved hair regrowth in a man with advanced hair loss.

Fractional lasers, combined with topical therapy, are a promising and safe treatment for hair loss.

Low-level light therapy significantly increased hair density and thickness in people with hair loss, but they didn't notice a difference.

Flibanserin may help improve sexual symptoms in various conditions beyond its approved use.

Dutasteride more effective than finasteride for hair growth; SM04554 safe and potentially effective for hair loss.

Long-term antiandrogen use may increase aggressive prostate cancer risk.